[Fundamental studies, reference values, and clinical evaluation of abnormal prothrombin PIVKA-II assay using monoclonal antibody (E-1023)].
Sakurabayashi
I
I
Kawai
T
T
Omizo
R
R
Hattori
N
N
Ishii
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal; D015415:Biomarkers; D014408:Biomarkers, Tumor / Q000032:analysis*; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis; D002648:Child; D005069:Evaluation Studies as Topic; D006801:Humans; D007124:Immunoenzyme Techniques; D008113:Liver Neoplasms / Q000175:diagnosis; D008875:Middle Aged; D011498:Protein Precursors / Q000032:analysis* / Q000276:immunology; D011516:Prothrombin / Q000032:analysis* / Q000276:immunology; D011933:Reagent Kits, Diagnostic / Q000592:standards*; D012016:Reference Values
D000911:Antibodies, Monoclonal; D015415:Biomarkers; D014408:Biomarkers, Tumor; D011498:Protein Precursors; D011933:Reagent Kits, Diagnostic; C008208:acarboxyprothrombin; D011516:Prothrombin